Literature DB >> 2085707

Effects of carbachol and (-)-N6-phenylisopropyladenosine on myocardial inositol phosphate content and force of contraction.

C Kohl1, B Linck, W Schmitz, H Scholz, J Scholz, M Tóth.   

Abstract

1. The effects of carbachol and the A1-adenosine receptor agonist (-)-N6-phenylisopropyladenosine (PIA) on force of contraction and inositol lipid metabolism were studied in electrically driven left auricles and papillary muscles isolated from guinea-pig hearts. Both carbachol and PIA (0.01-10 microM) had concentration-dependent negative inotropic effects in auricles. In papillary muscles PIA had no inotropic effect. Carbachol also had no inotropic effect at low concentrations (0.01-1 microM) but at 10-100 microM it exerted a slight positive inotropic effect. 2. In auricles and papillary muscles both carbachol and PIA concentration-dependently increased inositol trisphosphate (IP3; significant at 1 microM). Accordingly phosphatidylinositol bisphosphate (PIP2), the precursor of IP3, was reduced. All effects of carbachol and PIA were antagonized by atropine (10 microM) and 1,3-dipropyl-8-cyclopentylxanthine (DPCPX; 20 microM) respectively, indicating receptor-mediated effects. 3. In auricles the negative inotropic effects of carbachol and PIA preceded the increase in IP3. 4. In papillary muscles the increase in IP3 preceded the slight positive inotropic effect of carbachol, indicating that the M-cholinoceptor-mediated increase in IP3 and force of contraction may be related. However, PIA showed a comparable increase in IP3 but no inotropic effect, indicating a dissociation between those parameters. 5. In conclusion, in previous studies a close relation between increases in IP3 and force of contraction has been shown after alpha 1-adrenoceptor stimulation. The present study with carbachol supports this view. However, the present data for PIA could not show such a close relationship, questioning the role of IP3 as an endogenous regulator of force of contraction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085707      PMCID: PMC1917821          DOI: 10.1111/j.1476-5381.1990.tb14165.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

Review 1.  The parasympathetic neuroeffector junction of the heart.

Authors:  K Löffelholz; A J Pappano
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

2.  The mechanism by which adenosine and cholinergic agents reduce contractility in rat myocardium. Correlation with cyclic adenosine monophosphate and receptor densities.

Authors:  J Linden; C E Hollen; A Patel
Journal:  Circ Res       Date:  1985-05       Impact factor: 17.367

Review 3.  [Inositol trisphosphate, a new "second messenger" for positive inotropic effects on the heart?].

Authors:  J Scholz
Journal:  Klin Wochenschr       Date:  1989-03-01

4.  Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea-pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect.

Authors:  M Böhm; R Brückner; I Hackbarth; B Haubitz; R Linhart; W Meyer; B Schmidt; W Schmitz; H Scholz
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

5.  Evidence for a carbachol stimulated phosphatidylinositol effect in heart.

Authors:  E E Quist
Journal:  Biochem Pharmacol       Date:  1982-10-01       Impact factor: 5.858

6.  Muscarinic stimulation of phosphatidylinositol metabolism in atria.

Authors:  S L Brown; J H Brown
Journal:  Mol Pharmacol       Date:  1983-11       Impact factor: 4.436

Review 7.  Inositol trisphosphate, a novel second messenger in cellular signal transduction.

Authors:  M J Berridge; R F Irvine
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

8.  Inositol trisphosphate does not release Ca2+ from permeabilized cardiac myocytes and sarcoplasmic reticulum.

Authors:  M A Movsesian; A P Thomas; M Selak; J R Williamson
Journal:  FEBS Lett       Date:  1985-06-17       Impact factor: 4.124

9.  Release of Ca2+ from a non-mitochondrial store site in peritoneal macrophages treated with saponin by inositol 1,4,5-trisphosphate.

Authors:  M Hirata; E Suematsu; T Hashimoto; T Hamachi; T Koga
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

10.  Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes.

Authors:  I L Buxton; L L Brunton
Journal:  J Biol Chem       Date:  1983-09-10       Impact factor: 5.157

View more
  7 in total

Review 1.  Adenosine and bradykinin: are they independent triggers of preconditioning?

Authors:  T Miura
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

2.  A1 adenosine receptors expressed in CHO-cells couple to adenylyl cyclase and to phospholipase C.

Authors:  S Freund; M Ungerer; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

3.  Adenosine release mediates cyanide-induced suppression of CA1 neuronal activity.

Authors:  P J Zhu; K Krnjević
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

4.  Stimulation of protein phosphatases as a mechanism of the muscarinic-receptor-mediated inhibition of cardiac L-type Ca2+ channels.

Authors:  S Herzig; A Meier; M Pfeiffer; J Neumann
Journal:  Pflugers Arch       Date:  1995-02       Impact factor: 3.657

5.  Loss of myocardial protection from ischemic preconditioning following chronic exposure to R(-)-N6-(2-phenylisopropyl)adenosine is related to defect at the adenosine A1 receptor.

Authors:  M W Hashimi; J D Thornton; J M Downey; M V Cohen
Journal:  Mol Cell Biochem       Date:  1998-09       Impact factor: 3.396

6.  Evidence for deactivation of both ectosolic and cytosolic 5'-nucleotidase by adenosine A1 receptor activation in the rat cardiomyocytes.

Authors:  M Kitakaze; M Hori; T Minamino; S Takashima; K Komamura; K Node; T Kurihara; T Morioka; H Sato; M Inoue
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

7.  Adenoprotection of the heart involves phospholipase C-induced activation and translocation of PKC-epsilon to RACK2 in adult rat and mouse.

Authors:  Richard A Fenton; Satoshi Komatsu; Mitsuo Ikebe; Lynne G Shea; James G Dobson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-12       Impact factor: 4.733

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.